Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HM

Key facts

Sponsor

Gamida Cell ltd

Principal Investigator

Mitchell Horwitz, MD

Duke University

Intervention

NiCord®(drug)

Enrollment

36 enrolled

Eligibility

12-65 years · All sexes

Timeline

2013 – 2018

Study locations (15)

• Cedars-Sinai Medical Center, Los Angeles, California, United States
• Loyola University, Cardinal Bernardin Cancer Center, Maywood, Illinois, United States
• University of Minnesota, Minneapolis, Minnesota, United States
• Steven and Alexandra Cohen Children's Medical Center, New York, New York, United States
• Duke University Medical Center, Durham, North Carolina, United States
• Cleveland Clinic, Cleveland, Ohio, United States
• Oregon Health & Science University, Portland, Oregon, United States
• Vanderbilt, Nashville, Tennessee, United States
• Children Hospital Gaslini Scientific Institute, Genoa, Italy
• University of Turin, Turin, Italy
• University Medical Center Utrecht, Utrecht, Netherlands
• National University Cancer Institute, Singapore, Singapore
• Singapore General Hospital, Singapore, Singapore
• University Hospital Vall d´Hebron, Barcelona, Spain
• Hospital Universitario La Fe, Valencia, Spain

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT05621291
  A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...
  National Cancer Institute (NCI)
• RECRUITINGPHASE2NCT06738368
  Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
  University of Washington
• ENROLLING BY INVITATIONNCT07511959
  Autologous Exosomes From Platelet-rich Plasma as a Modern Tool of Regenerative Dentistry
  Wroclaw Medical University
• RECRUITINGNANCT07191119
  Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
  St. Jude Children's Research Hospital
• RECRUITINGPHASE2NCT07275762
  Y-4 to Treat the Postherpetic Neuralgia
  Neurodawn Pharmaceutical Co., Ltd.
• RECRUITINGNANCT07177183
  Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning Failure
  University Hospital Ostrava
• ENROLLING BY INVITATIONNCT07515430
  The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic Leukemia
  Sun Yat-sen University
• RECRUITINGNANCT07201974
  Virtual Reality for Post-Stroke Gait Rehabilitation
  McGill University

See all trials for Acute lymphoblastic leukemia →